Improving 10-year cardiovascular disease risk prediction using automated machine learning
Aims To develop a cardiovascular disease (CVD) risk prediction model with improved accuracy and interpretability by integrating diverse risk factors and applying Automated Machine Learning (AutoML), thereby enhancing clinical utility over conventional models. Methods This is a prospective cohort study. Data were obtained from the Multi-Ethnic Study of Atherosclerosis (MESA), including baseline and fifth follow-up visits, comprising 4713 participants. Exercise and dietary data were harmonized via Metabolic Equiva…
H2O AutoML trained on 4713 MESA participants using 21 selected predictors achieved higher discrimination than logistic regression and traditional ML models, reaching AUC 0.882 and accuracy 0.864, intended as a practical tool for clinician risk stratification.
Evidence
- Peer-reviewedInternational Journal of Cardiology2026-09-05
How should this claim be treated?
Truvace Impact Record TRV-2026-1009, v1: “Improving 10-year cardiovascular disease risk prediction using automated machine learning.” Truvace, 2026-09-07. /record/TRV-2026-1009 (accessed at citation time). sha256 430789624b46e10b…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1009 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace